Siemens Healthineers stock: RBC raised target for Siemens Healthineers stock to EUR 48.00

Published on 10/19/2026 at 15:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due November 5, 2026. Siemens Healthineers stock costs EUR 40.92 on October 19, 2026, down 1.28 percent versus the Xetra close.

Analyst view and trading levels

On October 15, 2026, RBC Capital Markets lifted its target from EUR 45.00 to EUR 48.00.
Siemens Healthineers schedules fourth-quarter results for November 5, 2026.
Siemens Healthineers stock costs EUR 40.92 at Lang & Schwarz on October 19, 2026 at 3:37 p.m. CEST, 1.28 percent below the Xetra close of October 16, 2026.
The company had a market capitalization of EUR 45.7 billion and a price-to-earnings ratio of 20.60 on October 19, 2026.

Bauhaus-Poster mit geometrischen Formen und Text MEDTECH in Primärfarben — Siemens Healthineers DE000SHL1006 gestaltet Bauhaus-Poster mit geometrischen Formen und stilisiertem Scanner-Ring sowie MEDTECH-Schriftzug, Illustration mit AI erstellt.

According to Yahoo Finance, RBC Capital Markets raised its Siemens Healthineers (ISIN DE000SHL1006) target from EUR 45.00 to EUR 48.00 in a study published October 15, 2026, and retained its Outperform rating. The new target is 17.30 percent above the EUR 40.92 price at Lang & Schwarz. At 3:37 p.m. CEST on October 19, 2026, the stock was down 1.28 percent versus the Xetra close.

November 5 results date

Siemens Healthineers lists November 5, 2026, for fourth-quarter results and the analyst call. The date gives the RBC target a clear near-term test, because the next report can update the market view on growth, margins and the full-year outcome.

Price sits below yearly high

The Lang & Schwarz bid was EUR 40.90 and the ask was EUR 40.94 at 3:37 p.m. CEST. Finance data placed trading volume at 180,412 shares at 3:34 p.m. CEST, against an average volume of 912,756 shares.

At EUR 40.92, Siemens Healthineers stood 17.68 percent below its 52-week high of EUR 49.71 and 24.72 percent above its 52-week low of EUR 32.81 on October 19, 2026. The range leaves the stock closer to its yearly midpoint than to either extreme.

Valuation and November date

Market capitalization stood at EUR 45.7 billion on October 19, 2026. The price-to-earnings ratio was 20.60, while the scheduled November 5 report is the next company date with direct relevance for that valuation.

Comparison with peers

Siemens Healthineers (Xetra, EUR): minus 1.28 percent, price-to-earnings ratio 20.60, market capitalization EUR 45.7 billion.

Philips (Euronext Amsterdam, EUR): minus 1.73 percent, price-to-earnings ratio 19.59, market capitalization EUR 22.2 billion.

GE HealthCare (Nasdaq, USD): minus 0.17 percent, price-to-earnings ratio 20.15, market capitalization USD 31.4 billion.

Trading level and next test

RBC's EUR 48.00 target sits above the current euro quote, while the stock's 52-week range shows that the market has not returned to its yearly high. The November 5 results date is the next scheduled point for fresh operating figures.

Siemens Healthineers was trading at EUR 40.92 at Lang & Schwarz on October 19, 2026 at 3:37 p.m. CEST, down 1.28 percent versus the Xetra close of October 16, 2026 at EUR 41.45. The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.